相关实验视频
Updated: Jan 7, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.8K
在新生儿群体中达普托米辛的有效性和安全性
Celia Permuy1,2, Jone Ruiz-Azcárate1, Laura Sánchez García1
1From the Neonatology Department, La Paz University Hospital, Madrid, Spain.
The Pediatric infectious disease journal
|December 31, 2025
概括
达普托米辛有效地治疗了新生儿的格拉姆阳性败血症,当万科米辛失败时,显示出快速的细菌清除和良好的耐受性. 肝酶的升高也被注意到,但在不停止治疗的情况下得到解决.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 阳性败血症是新生儿疾病和死亡的主要原因.
- 范科米辛是标准的药物,但面临耐药性和监测问题.
- 达普托米辛具有强烈的活性和低耐药性,但新生儿数据有限.
研究的目的:
- 为了评估达普托米辛在患有格兰阳性败血症的新生儿中的疗效和安全性.
- 在困难的情况下,评估达普素作为万科素的替代品.
- 分析一组主要是早产婴儿的结果.
主要方法:
- 对患有格拉姆阳性感染的婴儿进行回顾性研究 (2019-2024年).
- 达普托米辛在万科米辛失败或不耐受后每12小时服用6毫克/公斤.
- 收集关于人口统计,微生物学,治疗,不良事件和结果的数据.
主要成果:
- 53名早产婴儿接受了达普托米辛; 77.4%的感染是耐美西林的 Staphylococcus epidermidis.
- 血液培养在4天内清除了90.4%的可评估病例.
- 24%的人经历过渡性肝酶升高;没有观察到肌肉/神经毒性. 总体死亡率为24.5%,感染导致的死亡率为7.5%.
结论:
- 达普托米辛表现出快速的微生物清除,并且在这个新生儿队列中耐受良好,包括非常早产的婴儿.
- 它显示了作为替代品的承诺 范科米辛 对于格兰阳性败血症.
- 有必要对高风险感染中早期使用达普素进行进一步的前性研究.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Drug Dosing: Infants and Children
229
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229
Pharmacokinetics in Pediatric Patients: Drug Distribution
234
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
225
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
Pharmacokinetics in Pediatric Patients: Drug Metabolism
171
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
Antimicrobial Effectiveness
876
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
876

